Phase 2 Study Of Alemtuzumab Added To Dose-Adjusted Epoch-R In Relapsed And Refractory Aggressive B-Cell LymphomasSanjal Desai,Christopher Melani,Kieron Dunleavy,Stefania Pittaluga,Mark A. Ahlman,Andrea Nicole Lucas,Seth M. Steinberg,Elaine S. Jaffe,Mark Roschewski,Wyndham WilsonBLOOD(2019)引用 0|浏览9暂无评分摘要Introduction:更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要